Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
new products
![Meta's Ray-Ban Smart Glasses Fail to Catch On](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Meta039s-Ray-Ban-Smart-Glasses-Fail-to-Catch-On-400x400.jpeg)
Meta's Ray-Ban Smart Glasses Fail to Catch On
- By nasdaqpicks.com
- . 3 August 2023
The company plans the release of the second generation as less than 10% of the devices purchased are used monthly, an internal company document shows.
![Toyota's Land Cruiser to Return to U.S.](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Toyota039s-Land-Cruiser-to-Return-to-US-400x400.jpeg)
Toyota's Land Cruiser to Return to U.S.
- By nasdaqpicks.com
- . 2 August 2023
New version of off-roading SUV aims to compete with Jeep and Ford Bronco. Source link
![Venture Capitalist Seeks to Spur Drug Development for Rare Autoimmune Disease](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Venture-Capitalist-Seeks-to-Spur-Drug-Development-for-Rare-Autoimmune-400x400.jpeg)
Venture Capitalist Seeks to Spur Drug Development for Rare Autoimmune Disease
- By nasdaqpicks.com
- . 1 August 2023
Venture capitalist Luke Evnin has financed several successful biotechnology startups that develop treatments for cancer. Now he is encouraging drugmakers to tackle another disease: a rare autoimmune condition that
![Pfizer Misses Revenue Expectations, Bets on Drug Launches to Ease Shortfall](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Pfizer-Misses-Revenue-Expectations-Bets-on-Drug-Launches-to-Ease-400x400.jpeg)
Pfizer Misses Revenue Expectations, Bets on Drug Launches to Ease Shortfall
- By nasdaqpicks.com
- . 1 August 2023
The company is rolling out 19 products or new uses within 18 months, CEO Albert Bourla said. Source link
![Volkswagen Seeks to Reclaim China Crown in Deal With EV Maker](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Volkswagen-Seeks-to-Reclaim-China-Crown-in-Deal-With-EV-400x400.jpeg)
Volkswagen Seeks to Reclaim China Crown in Deal With EV Maker
- By nasdaqpicks.com
- . 28 July 2023
The German auto giant bought a stake in Chinese rival XPeng after praising the dynamism and innovation of local automakers. Source link
![Facebook Parent Meta Expected to Report Sales Growth as Turnaround Continues](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Facebook-Parent-Meta-Expected-to-Report-Sales-Growth-as-Turnaround-400x400.jpeg)
Facebook Parent Meta Expected to Report Sales Growth as Turnaround Continues
- By nasdaqpicks.com
- . 26 July 2023
The social-media giant has seen a surge after cutting costs and improving ad-targeting. Source link
![Fire on Car-Carrier Ship Off Dutch Coast Kills One](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Fire-on-Car-Carrier-Ship-Off-Dutch-Coast-Kills-One-400x400.jpeg)
Fire on Car-Carrier Ship Off Dutch Coast Kills One
- By nasdaqpicks.com
- . 26 July 2023
The coast guard is investigating whether the blaze started in one of the electric vehicles onboard. Source link
![Meta’s Threads Isn’t Labeling Propaganda Accounts From Russia, China State Media](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Metas-Threads-Isnt-Labeling-Propaganda-Accounts-From-Russia-China-State-400x400.jpeg)
Meta’s Threads Isn’t Labeling Propaganda Accounts From Russia, China State Media
- By nasdaqpicks.com
- . 26 July 2023
What to Read Next Source link
![Samsung to Launch New Galaxy Z Fold, Flip Phones Amid Slow Adoption So Far](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Samsung-to-Launch-New-Galaxy-Z-Fold-Flip-Phones-Amid-400x400.jpeg)
Samsung to Launch New Galaxy Z Fold, Flip Phones Amid Slow Adoption So Far
- By nasdaqpicks.com
- . 26 July 2023
The smartphone maker on Wednesday will show off the latest models of devices that have had limited success outside of South Korea. Source link
![Biogen to Cut Roughly 11% of Workforce](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Biogen-to-Cut-Roughly-11-of-Workforce-400x400.jpeg)
Biogen to Cut Roughly 11% of Workforce
- By nasdaqpicks.com
- . 25 July 2023
The biotech cited the launch of Alzheimer’s drug Leqembi as part of its new focus on big-return products. Source link